155 related articles for article (PubMed ID: 35309313)
1. Comparative Analysis of Extracellular Vesicles in Patients with Severe and Mild Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Bonilla H; Hampton D; Marques de Menezes EG; Deng X; Montoya JG; Anderson J; Norris PJ
Front Immunol; 2022; 13():841910. PubMed ID: 35309313
[TBL] [Abstract][Full Text] [Related]
2. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.
Giloteaux L; O'Neal A; Castro-Marrero J; Levine SM; Hanson MR
J Transl Med; 2020 Oct; 18(1):387. PubMed ID: 33046133
[TBL] [Abstract][Full Text] [Related]
3. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
[TBL] [Abstract][Full Text] [Related]
4. Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome.
Eguchi A; Fukuda S; Kuratsune H; Nojima J; Nakatomi Y; Watanabe Y; Feldstein AE
Brain Behav Immun; 2020 Feb; 84():106-114. PubMed ID: 31759091
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of extracellular vesicle protein cargo in female myalgic encephalomyelitis/chronic fatigue syndrome cases and sedentary controls in response to maximal exercise.
Giloteaux L; Glass KA; Germain A; Franconi CJ; Zhang S; Hanson MR
J Extracell Vesicles; 2024 Jan; 13(1):e12403. PubMed ID: 38173127
[TBL] [Abstract][Full Text] [Related]
6. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J
Front Immunol; 2020; 11():582330. PubMed ID: 33329554
[TBL] [Abstract][Full Text] [Related]
7. Circulating extracellular vesicles as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis: an exploratory pilot study.
Castro-Marrero J; Serrano-Pertierra E; Oliveira-Rodríguez M; Zaragozá MC; Martínez-Martínez A; Blanco-López MDC; Alegre J
J Extracell Vesicles; 2018; 7(1):1453730. PubMed ID: 29696075
[TBL] [Abstract][Full Text] [Related]
8. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
[TBL] [Abstract][Full Text] [Related]
9. Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients.
Nguyen T; Staines D; Nilius B; Smith P; Marshall-Gradisnik S
Biol Res; 2016 May; 49(1):27. PubMed ID: 27245705
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.
Maksoud R; Magawa C; Eaton-Fitch N; Thapaliya K; Marshall-Gradisnik S
BMC Med; 2023 May; 21(1):189. PubMed ID: 37226227
[TBL] [Abstract][Full Text] [Related]
11. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
Front Immunol; 2019; 10():796. PubMed ID: 31057538
[TBL] [Abstract][Full Text] [Related]
12. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
Domingo JC; Cordobilla B; Ferrer R; Giralt M; Alegre-Martín J; Castro-Marrero J
Antioxid Redox Signal; 2021 Jun; 34(18):1420-1427. PubMed ID: 33353469
[TBL] [Abstract][Full Text] [Related]
13. Assessing diagnostic value of microRNAs from peripheral blood mononuclear cells and extracellular vesicles in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Almenar-Pérez E; Sarría L; Nathanson L; Oltra E
Sci Rep; 2020 Feb; 10(1):2064. PubMed ID: 32034172
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
Maes M; Bosmans E; Kubera M
Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
Maes M; Twisk FN; Ringel K
Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
[TBL] [Abstract][Full Text] [Related]
16. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.
Sotzny F; Blanco J; Capelli E; Castro-Marrero J; Steiner S; Murovska M; Scheibenbogen C;
Autoimmun Rev; 2018 Jun; 17(6):601-609. PubMed ID: 29635081
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Lutz L; Rohrhofer J; Zehetmayer S; Stingl M; Untersmayr E
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572574
[TBL] [Abstract][Full Text] [Related]
18. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S
Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.
Gravelsina S; Vilmane A; Svirskis S; Rasa-Dzelzkaleja S; Nora-Krukle Z; Vecvagare K; Krumina A; Leineman I; Shoenfeld Y; Murovska M
Front Immunol; 2022; 13():928945. PubMed ID: 36300129
[TBL] [Abstract][Full Text] [Related]
20. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
